Pear Therapeutics ' digital insomnia therapeutic will put FDA ' s PreCert framework through its paces

CEO and President Dr. Corey McCann said that Somryst, a digital treatment for chronic insomnia and depression, is the first software as a medical device product to be submitted through the regulator ' s pilot pathway.  
Source: mobihealthnews - Category: Information Technology Source Type: news